全文获取类型
收费全文 | 135925篇 |
免费 | 9431篇 |
国内免费 | 630篇 |
专业分类
耳鼻咽喉 | 1651篇 |
儿科学 | 3418篇 |
妇产科学 | 2444篇 |
基础医学 | 17376篇 |
口腔科学 | 2895篇 |
临床医学 | 13295篇 |
内科学 | 27977篇 |
皮肤病学 | 1751篇 |
神经病学 | 11946篇 |
特种医学 | 5396篇 |
外科学 | 21817篇 |
综合类 | 1916篇 |
现状与发展 | 1篇 |
一般理论 | 173篇 |
预防医学 | 12397篇 |
眼科学 | 2916篇 |
药学 | 9599篇 |
2篇 | |
中国医学 | 179篇 |
肿瘤学 | 8837篇 |
出版年
2023年 | 671篇 |
2022年 | 1048篇 |
2021年 | 2571篇 |
2020年 | 1466篇 |
2019年 | 2395篇 |
2018年 | 2924篇 |
2017年 | 2112篇 |
2016年 | 2229篇 |
2015年 | 2714篇 |
2014年 | 4015篇 |
2013年 | 6055篇 |
2012年 | 8865篇 |
2011年 | 9436篇 |
2010年 | 5253篇 |
2009年 | 4806篇 |
2008年 | 8382篇 |
2007年 | 8984篇 |
2006年 | 8558篇 |
2005年 | 8711篇 |
2004年 | 8370篇 |
2003年 | 7867篇 |
2002年 | 7678篇 |
2001年 | 1275篇 |
2000年 | 1049篇 |
1999年 | 1396篇 |
1998年 | 1626篇 |
1997年 | 1303篇 |
1996年 | 1251篇 |
1995年 | 1216篇 |
1994年 | 1031篇 |
1993年 | 1004篇 |
1992年 | 838篇 |
1991年 | 863篇 |
1990年 | 753篇 |
1989年 | 731篇 |
1988年 | 753篇 |
1987年 | 737篇 |
1986年 | 759篇 |
1985年 | 835篇 |
1984年 | 907篇 |
1983年 | 867篇 |
1982年 | 1130篇 |
1981年 | 1156篇 |
1980年 | 964篇 |
1979年 | 631篇 |
1978年 | 668篇 |
1977年 | 597篇 |
1976年 | 519篇 |
1975年 | 468篇 |
1974年 | 471篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Christabel E. Fowler Elia Beniash Yasuo Yamakoshi James P. Simmer Henry C. Margolis 《European journal of oral sciences》2006,114(S1):297-303
An amorphous silica mineralization technique was used to produce inorganic/protein composites to elucidate the structure and mechanism of formation of amelogenin assemblies, which may play an important role in regulating enamel structure during the initial stages of amelogenesis. Full-length recombinant amelogenins from mouse (rM179) and pig (rP172) were investigated along with key degradation products (rM166 and native P148) lacking the hydrophilic C terminus found in parent molecules. The resulting products were examined using transmission electron microscopy and/or small-angle X-ray scattering. Using protein concentrations of 0.1–3 mg ml−1 , large monodisperse spheres of remarkably similar mean diameters were observed using rM179 (124 ± 4 nm) and rP172 (126 ± 7 nm). These spheres also exhibited 'internal structure', comprising nearly spherical monodisperse particles of ≈ 20 nm in diameter. In the presence of rM166, P148, and bovine serum albumin (control), large unstructured and randomly shaped particles (250–1000 nm) were observed. Without added protein, large dense spherical particles of silica (mean ≈ 500 nm) lacking internal structure were produced. These findings demonstrate that full-length amelogenins have the ability to form higher-order structures, whereas amelogenins that lack the hydrophilic C terminus do not. The results also suggest that full-length amelogenin can guide the formation of organized mineralized structures through co-operative interactions between assembling protein and forming mineral. 相似文献
62.
63.
64.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
65.
66.
67.
68.
69.
70.
Christopher D Gardner James L Zehnder Alison J Rigby Joel R Nicholus John W Farquhar 《Blood coagulation & fibrinolysis》2007,18(8):787-793
Several case reports have implicated Ginkgo biloba in clinically adverse bleeding disorders. Ginkgo biloba has been reported to increase pain-free walking distance among patients with peripheral artery disease (PAD). Standard PAD therapy includes 325 mg/day aspirin. The objective of this study was to examine potential adverse effects of concomitant aspirin and Ginkgo biloba on platelet function. Ginkgo biloba (EGb 761, 300 mg/day) was compared with placebo for effects on measures of platelet aggregation among adults consuming 325 mg/day aspirin in a randomized, double-blind, placebo-controlled, parallel design trial of 4-week duration. Participants were adults, age 69 +/- 10 years, with PAD or risk factors for cardiovascular disease. Outcome measures included platelet function analysis (PFA-100 analyzer) using ADP as an agonist (n = 26 placebo; n = 29 ginkgo), and platelet aggregation using ADP, epinephrine, collagen and ristocetin as agonists (n = 21 placebo; n = 23 ginkgo). Participants kept daily logs of bleeding or bruising episodes. There were no clinically or statistically significant differences between treatment groups for any agonists, for either PFA-100 analysis or platelet aggregation. Reports of bleeding or bruising were infrequent and similar for both study groups. In conclusion, in older adults with PAD or cardiovascular disease risk, a relatively high dose of Ginkgo biloba combined with 325 mg/day daily aspirin did not have a clinically or statistically detectable impact on indices of coagulation examined over 4 weeks, compared with the effect of aspirin alone. No adverse bleeding events were observed, although the trial was limited to a small sample size. 相似文献